Autonomix Medical, Inc. Common Stock
AMIX · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $4,725 | $2,225 | $745 | $4 |
| G&A Expenses | $6,863 | $5,249 | $1,245 | $13,590 |
| SG&A Expenses | $6,863 | $5,249 | $1,245 | $13,590 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $4,556 | $0 | $0 |
| Operating Expenses | $11,588 | $12,030 | $1,990 | $13,594 |
| Operating Income | -$11,588 | -$12,030 | -$1,990 | -$13,594 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $178 | -$3,396 | $0 | $266 |
| Pre-Tax Income | -$11,410 | -$15,426 | -$1,990 | -$13,329 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$11,410 | -$15,426 | -$1,990 | -$13,329 |
| % Margin | – | – | – | – |
| EPS | -6.46 | -21.1 | -0.11 | -0.71 |
| % Growth | 69.4% | -19,081.8% | 84.5% | – |
| EPS Diluted | -6.46 | -21.09 | -0.11 | -0.71 |
| Weighted Avg Shares Out | 1,766 | 731 | 18,794 | 18,794 |
| Weighted Avg Shares Out Dil | 1,766 | 731 | 18,794 | 18,794 |
| Supplemental Information | – | – | – | – |
| Interest Income | $354 | $127 | $0 | $0 |
| Interest Expense | $176 | $79 | $0 | $218 |
| Depreciation & Amortization | $183 | $81 | $0 | $13,594 |
| EBITDA | -$11,051 | -$15,266 | -$1,990 | $0 |
| % Margin | – | – | – | – |